Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy. (2012)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201206-1056oc
PubMed Identifier: 22955314
Publication URI: http://europepmc.org/abstract/MED/22955314
Type: Journal Article/Review
Volume: 186
Parent Publication: American journal of respiratory and critical care medicine
Issue: 9
ISSN: 1073-449X